| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Groves Regina E is a Director at ATRC, with reported holdings spanning 2 companies. Recent filings cover 3 purchases and 5 sales. Those positions are worth an estimated $1.9M at current prices.
Our model assigns Groves Regina E a middling insider score of 56/100, based on 4 past trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of +10.3%.
Groves Regina E's largest disclosed position is in ATRC as Director, worth about $1.9M. The recent filings there lean toward selling, a net 19,908 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | ATRC Atricure, Inc. | Director | Sell | 5,313 | $54.22 | $288,070.86 | -13.3% | - | - | |
| Aug 6, 2025 | ATRC Atricure, Inc. | Director | Sell | 2,452 | $36.82 | $90,282.64 | -6.8% | -10.3% | +8.1% | |
| Sep 15, 2021 | ATRC Atricure, Inc. | Director | Sell | 3,156 | $74.73 | $235,847.88 | -16.3% | -10.1% | -38.7% | |
| May 26, 2021 | ATRC Atricure, Inc. | Director | Sell | 4,208 | $71.95 | $302,765.60 | -17.9% | +4.1% | -43.3% | |
| Apr 30, 2021 | ATRC Atricure, Inc. | Director | Buy | 34 | $76.68 | $2,607.12 | +0.2% | +8.5% | -32.6% | |
| Sep 14, 2020 | ATRC Atricure, Inc. | Director | Sell | 6,313 | $41.83 | $264,072.79 | -22.4% | - | - | |
| Sep 12, 2019 | ATRC Atricure, Inc. | Director | Buy | 500 | $24.86 | $12,430.00 | +2.0% | - | - | |
| Mar 1, 2018 | ATRC Atricure, Inc. | Director | Buy | 1,000 | $17.43 | $17,430.00 | +10.6% | - | - |